Parabilis Medicines, Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 14 purchases
- RA CAPITAL MANAGEMENT, L.P.Board member · Jul 22, 2026Bought 47,250 sharesabout $1.4 million ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jul 21, 2026Bought 21,696 sharesabout $607 thousand ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jul 21, 2026Bought 6,504 sharesabout $190 thousand ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jul 21, 2026Bought 37,723 sharesabout $1.1 million ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jul 20, 2026Bought 98,433 sharesabout $2.7 million ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jul 20, 2026Bought 32,987 sharesabout $914 thousand ·
- SEBULSKY ALANBoard member · Jun 15, 2026Bought 5,000 sharesabout $130 thousand ·
- SEBULSKY ALANBoard member · Jun 15, 2026Bought 4,065 sharesabout $110 thousand ·
- SEBULSKY ALANBoard member · Jun 12, 2026Bought 8,435 sharesabout $233 thousand ·
- Levy GuyLarge shareholder · Jun 11, 2026Bought 375,000 sharesabout $7.5 million ·
- Levy GuyLarge shareholder · Jun 11, 2026Bought 125,000 sharesabout $2.5 million ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jun 11, 2026Bought 19,728,353 sharesabout $394.6 million ·
- RA CAPITAL MANAGEMENT, L.P.Board member · Jun 11, 2026Bought 1,460,397 sharesabout $29.2 million ·
- SEBULSKY ALANBoard member · Jun 11, 2026Bought 12,500 sharesabout $250 thousand ·
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
- Signed a major agreementNews report (8-K)Nov 5, 2026
- Shared information with investorsNews report (8-K)Sep 15, 2026
- An executive or board member joined or leftNews report (8-K)Sep 2, 2026
- An executive or board member joined or left; Shared information with investorsNews report (8-K)Aug 25, 2026
- Quarterly reportQuarterly report (10-Q)Aug 13, 2026
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.